These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 9568181)

  • 41. Cytokine release of whole blood from adult female donors challenged with mistletoe lectin-1 standardised mistletoe extract and E. coli endotoxin or phytohaemagglutinin (PHA).
    Braun JM; Blackwell CC; Weir DM; Beuth J
    Anticancer Res; 2003; 23(2B):1349-52. PubMed ID: 12820393
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Comparative lectinhistochemical studies on paraffin- and glycol methacrylate-embedded CNS tissue specimens from AIDS autopsies. Mistletoe lectin I (ML I) as cell-marker.
    Artigas J; Bachler B; Habedank S; Taube F; Franz H; Niedobitek F
    Zentralbl Pathol; 1992 Sep; 138(4):272-7. PubMed ID: 1420107
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Toxic proteins from European mistletoe (Viscum album L.): increase of intracellular IL-4 but decrease of IFN-gamma in apoptotic cells.
    Stein GM; Pfüller U; Schietzel M; Büssing A
    Anticancer Res; 2000; 20(3A):1673-8. PubMed ID: 10928090
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Immunologic effects of mistletoe lectins: a placebo-controlled study in healthy subjects.
    Huber R; Rostock M; Goedl R; Lüdtke R; Urech K; Klein R
    J Soc Integr Oncol; 2006; 4(1):3-7. PubMed ID: 16737665
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Opioid peptides and immunodysfunction in patients with major depression and anxiety disorders.
    Castilla-Cortázar I; Castilla A; Gurpegui M
    J Physiol Biochem; 1998 Dec; 54(4):203-15. PubMed ID: 10225412
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Comparison of the effects of various clinically applied mistletoe preparations on peripheral blood leukocytes.
    Elsässer-Beile U; Lusebrink S; Grussenmeyer T; Wetterauer U; Schultze-Seemann W
    Arzneimittelforschung; 1998 Dec; 48(12):1185-9. PubMed ID: 9893935
    [TBL] [Abstract][Full Text] [Related]  

  • 47. In vivo-induction of antibodies to mistletoe lectin-1 and viscotoxin by exposure to aqueous mistletoe extracts: a randomised double-blinded placebo controlled phase I study in healthy individuals.
    Klein R; Classen K; Berg PA; Lüdtke R; Werner M; Huber R
    Eur J Med Res; 2002 Apr; 7(4):155-63. PubMed ID: 12010650
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Mistletoe extract reduces the surgical suppression of natural killer cell activity in cancer patients. a randomized phase III trial.
    Schink M; Tröger W; Dabidian A; Goyert A; Scheuerecker H; Meyer J; Fischer IU; Glaser F
    Forsch Komplementmed; 2007 Feb; 14(1):9-17. PubMed ID: 17341882
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Lectin-related use of mistletoe: an experimental form of treatment with preclinically demonstrated potential risks].
    Gabius S; Gabius HJ
    Dtsch Med Wochenschr; 2002 Mar; 127(9):457-9. PubMed ID: 11870561
    [No Abstract]   [Full Text] [Related]  

  • 50. Complete amino acid sequence of the B chain of mistletoe lectin I.
    Soler MH; Stoeva S; Voelter W
    Biochem Biophys Res Commun; 1998 May; 246(3):596-601. PubMed ID: 9618256
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Ethanol suppression of the hypothalamic proopiomelanocortin level and the splenic NK cell cytolytic activity is associated with a reduction in the expression of proinflammatory cytokines but not anti-inflammatory cytokines in neuroendocrine and immune cells.
    Chen CP; Boyadjieva NI; Advis JP; Sarkar DK
    Alcohol Clin Exp Res; 2006 Nov; 30(11):1925-32. PubMed ID: 17067358
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Antitumoral effect of recombinant mistletoe lectin on chemically induced urinary bladder carcinogenesis in a rat model.
    Elsässer-Beile U; Ruhnau T; Freudenberg N; Wetterauer U; Mengs U
    Cancer; 2001 Mar; 91(5):998-1004. PubMed ID: 11251952
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Induction of Fas ligand (CD95L) by the toxic mistletoe lectins in human lymphocytes.
    Büssing A; Stein GM; Pfüller U; Schietzel M
    Anticancer Res; 1999; 19(3A):1785-90. PubMed ID: 10470116
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Selective killing of CD8+ cells with a 'memory' phenotype (CD62Llo) by the N-acetyl-D-galactosamine-specific lectin from Viscum album L.
    Büssing A; Stein GM; Pfüller U
    Cell Death Differ; 1998 Mar; 5(3):231-40. PubMed ID: 10200469
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Immunity and beta-endorphin concentrations in hypothalamus and plasma in rats with steroid-induced polycystic ovaries: effect of low-frequency electroacupuncture.
    Stener-Victorin E; Lindholm C
    Biol Reprod; 2004 Feb; 70(2):329-33. PubMed ID: 14561641
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Primary structure and molecular modeling of mistletoe lectin I from Viscum album.
    Eschenburg S; Krauspenhaar R; Mikhailov A; Stoeva S; Betzel C; Voelter W
    Biochem Biophys Res Commun; 1998 Jun; 247(2):367-72. PubMed ID: 9642133
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Generation of reactive oxygen intermediates (ROI) by the thionins from Viscum album L.
    Büssing A; Schaller G; Pfüller U
    Anticancer Res; 1998; 18(6A):4291-6. PubMed ID: 9891480
    [TBL] [Abstract][Full Text] [Related]  

  • 58. FLT3 ligand administration after hematopoietic cell transplantation increases circulating dendritic cell precursors that can be activated by CpG oligodeoxynucleotides to enhance T-cell and natural killer cell function.
    Chen W; Chan AS; Dawson AJ; Liang X; Blazar BR; Miller JS
    Biol Blood Marrow Transplant; 2005 Jan; 11(1):23-34. PubMed ID: 15625541
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Evaluation of pre-existent immunity in patients with primary breast cancer: molecular and cellular assays to quantify antigen-specific T lymphocytes in peripheral blood mononuclear cells.
    Rentzsch C; Kayser S; Stumm S; Watermann I; Walter S; Stevanoviç S; Wallwiener D; Gückel B
    Clin Cancer Res; 2003 Oct; 9(12):4376-86. PubMed ID: 14555509
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Differential binding of toxic lectins from Viscum album L., ML I and ML III, to human lymphocytes.
    Büssing A; Stein GM; Pfüller U; Schietzel M
    Anticancer Res; 1999; 19(6B):5095-9. PubMed ID: 10697516
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.